CytoVation

CytoVation

CytoVation

Lead compound CyPep-1 has world-wide patent protection and is currently in preclinical development for skin diseases and infections
Founded
2001
Raised
$2.2M
Follow us
Alexa global traffic share
Twitter followers
29 Jun 2017
€2,000,000
Venture capital

Cytovation Raises NOK20M in Funding

FinSMEs
+2